ARC Medical Inc. – Trademark Portfolio
Entity Type: 03
ARC Medical Inc. holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 8 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 4 Nice Classification classes. Currently, 3 trademarks are registered and 3 are pending. Notable registered marks include THERMOFLO, CIRCUITGUARD, and EVERY BREATH MATTERS. The owner is based in Tucker, GA.
4296 Cowan Road
Tucker, GA 30084
Showing of trademarks Trademarks
Trademark Classifications
ARC Medical Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does ARC Medical Inc. have?
ARC Medical Inc. has 10 U.S. trademarks filed with the USPTO. Of these, 3 registered, 3 pending, 4 abandoned.
What trademark classes does ARC Medical Inc. file in?
ARC Medical Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 35 (Advertising & Business). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are ARC Medical Inc.'s most well-known trademarks?
ARC Medical Inc.'s registered trademark portfolio includes well-known marks such as THERMOFLO, CIRCUITGUARD, and EVERY BREATH MATTERS. These are among 3 currently registered trademarks in the portfolio.
What is ARC Medical Inc.'s trademark registration success rate?
ARC Medical Inc. has a 43% trademark registration rate, with 3 out of 7 resolved applications resulting in successful registration. Currently, 3 applications are pending review.